The cost of simultaneous surgical standby for percutaneous transluminal coronary angioplasty

Wilson, James M.; Dunn, Edward J.; Wright, Creighton B.; Bailey, Warren W.; Callard, George M.; Melvin, David; Mitts, Donald L.; Will, Raymond J.; Flege, John B.

doi:10.1016/s0022-5223(19)36051-9

Cited by 14 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the latter would be inconsistent with the 1986 guidelines of the World Health Organization ISFC Task Force on Coronary Angiograms and Coronary Interventions (79) which state that "surgical standby is necessary for optimal safety of the procedure." That need is echoed by James M. Wilson and colleagues (78).…”

Section: Cost Comparisonmentioning

confidence: 98%

“…All of these disparities constrain the validity of current data for cost-effectiveness purposes. Although the importance placed on surgical standby can alter angioplasty cost estimates by a considerable amount, this element appears to be underestimated seriously in most published reports comparing PTCA to surgical revascularization (78). Furthermore, the use of data in current reports indicates that some patients approved for angioplasty would not have been candidates for CABG according to established criteria (70).…”

Section: Data Validitymentioning

confidence: 99%

“…This is also an instance in which some of the patients selected for PTCA would probably not have been candidates for CABG. Costs appear to be generally underestimated to date in PTCA analyses that fail to include provision of standby surgery, and distorted in data based on provider charges (78). These and other problems plague all of the existing data on PTCA.…”

Section: Why Randomize?mentioning

confidence: 99%

See 2 more Smart Citations

A Call for Randomized Controlled Cost-Effectiveness Analysis of Percutaneous Transluminal Coronary Angioplasty

Holly

1988

Int J Technol Assess Health Care

View full text Add to dashboard Cite

A rapidly evolving technology, percutaneous transluminal coronary angioplasty, is increasingly favored over bypass surgery for treating some types of coronary stenosis because of its less traumatic invasion, better recovery response, and lower initial cost. However, substantially higher failure rates in initial procedures offset PTCA's savings to an unknown extent and cloud analysis of its overall impact. Lack of randomized clinical data precludes valid cost-effectiveness comparison of the technologies at this time. Criteria for establishing valid data and evaluations of currently available data are described in this paper.

show abstract

Section: Cost Comparisonmentioning

confidence: 98%

Section: Data Validitymentioning

confidence: 99%

Section: Why Randomize?mentioning

confidence: 99%

See 1 more Smart Citation